Hims and Hers Shares Plummet as Compounded Weight Loss Drugs Face New Regulatory Challenges
The telehealth sector experienced a significant tremor this week as Hims and Hers Health witnessed a sharp decline in its market valuation.
by 
Josh Weiner
Josh Weiner